Which topical medication is recommended for treating an ulcerated skin lesion, such as a peristomal ulcer?

Topical Corticosteroids Are the Recommended First-Line Treatment

For peristomal ulcers and inflammatory skin lesions around a stoma, very potent topical corticosteroids—specifically clobetasol propionate 0.05%—are the recommended topical treatment, with aqueous/alcohol lotion formulations being particularly suitable to avoid compromising ostomy appliance adhesion.

Treatment Algorithm

First-Line Topical Therapy

Very potent topical corticosteroids are the cornerstone of treatment:

• Clobetasol propionate 0.05% applied to lesional skin 1, 2
• Formulation matters critically: Use aqueous/alcohol lotion preparations rather than creams or ointments, as the latter will cause stoma bags to detach and leak 3
• Alternative formulation: Aerosolized triamcinolone acetonide (55 mcg/spray) has shown complete resolution in recent case series without disrupting appliance adhesion 4

Dosing approach:

• Apply once daily initially for localized lesions
• For more extensive peristomal involvement, apply twice daily 5
• Continue until lesions show significant improvement (typically 2-4 weeks)
• Taper frequency gradually rather than stopping abruptly

When to Escalate Beyond Topical Therapy

If topical corticosteroids alone are insufficient after 1-3 weeks, consider:

1. Intralesional corticosteroids: Triamcinolone acetonide injected at ulcer margins 6, 7
2. Topical tacrolimus: Effective for refractory cases, particularly in ulcerative proctitis patients 8
3. Topical cyclosporine: Case reports show efficacy when combined with hydrocolloid dressings 9

Alternative Topical Agents

For specific scenarios:

• Silver sulfadiazine 1% + hyaluronic acid 0.2% combination cream: Demonstrated complete healing in chronic parastomal ulceration cases with reduced pain and purulent drainage 10
• Topical cromolyn sodium: Reported effective in some peristomal pyoderma gangrenosum cases 6

Critical Distinction: Peristomal Pyoderma Gangrenosum

Recognize the clinical features that suggest pyoderma gangrenosum rather than simple irritant dermatitis:

• Painful, rapidly enlarging necrotic ulcers
• Bluish undermined borders with violaceous wound edges
• Surrounding erythema
• Pathergy phenomenon (trauma triggers new lesions)
• Associated with inflammatory bowel disease in 60-70% of cases 6, 11

For confirmed peristomal pyoderma gangrenosum, topical therapy alone is often insufficient. While topical superpotent corticosteroids should still be used 6, 3, systemic therapy is typically required:

• Systemic corticosteroids remain first-line 2, 7
• Infliximab has become preferred when IBD is present 2
• Never relocate the stoma—this triggers new ulceration at the new site due to pathergy 6

Common Pitfalls to Avoid

1. Using cream or ointment bases: These compromise ostomy appliance seal integrity and cause leakage 3
2. Misdiagnosing pyoderma gangrenosum as infection: Biopsy excludes other causes but is not diagnostic for PG itself 6
3. Surgical intervention for PG: Stoma relocation causes recurrence; avoid unless absolutely necessary 6
4. Inadequate treatment duration: Chronic parastomal lesions may require months of therapy 9

Adjunctive Measures

Regardless of topical choice:

• Use nonadherent dressings to reduce bacterial superinfection and promote healing 1
• Consider antiseptic baths for extensive erosive lesions 1
• Review ostomy appliance fit and technique to minimize mechanical irritation 10

The evidence strongly supports very potent topical corticosteroids in appropriate formulations as the foundation of treatment, with the specific formulation choice (lotion vs. aerosol) being critical to maintaining ostomy function while treating the skin lesion effectively.